{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:14:31Z","timestamp":1784272471334,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejca.2021.09.044","type":"journal-article","created":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T03:38:37Z","timestamp":1635910717000},"page":"98-104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cutaneous melanoma attributable to UVR exposure in Denmark and Germany"],"prefix":"10.1016","volume":"159","author":[{"given":"Ulrike","family":"Keim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Amaral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Flatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-780X","authenticated-orcid":false,"given":"Claus","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.09.044_bib1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.5694\/j.1326-5377.1956.tb36084.x","article-title":"Some geographical aspects of the mortality from melanoma in Europeans","volume":"43","author":"Lancaster","year":"1956","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2021.09.044_bib2","first-page":"452","article-title":"Sunlight as a cause of melanoma; a clinical survey","volume":"44","author":"Lancaster","year":"1957","journal-title":"Med J Aust"},{"key":"10.1016\/j.ejca.2021.09.044_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.1989.03430030068036","article-title":"Harmful effects of ultraviolet radiation. Council on Scientific Affairs","volume":"262","year":"1989","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejca.2021.09.044_bib4","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1038\/nrdp.2015.3","article-title":"Melanoma","volume":"1","author":"Schadendorf","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ejca.2021.09.044_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ijc.27616","article-title":"International trends in the incidence of malignant melanoma 1953-2008--are recent generations at higher or lower risk?","volume":"132","author":"Erdmann","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2021.09.044_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008390-199311000-00002","article-title":"How much melanoma is caused by sun exposure?","volume":"3","author":"Armstrong","year":"1993","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2021.09.044_bib7","first-page":"31","article-title":"Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States","volume":"68","author":"Islami","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2021.09.044_bib8","doi-asserted-by":"crossref","first-page":"105728","DOI":"10.1016\/j.ypmed.2019.05.016","article-title":"Corrigendum to \u201cEstimates of the current and future burden of melanoma attributable to ultraviolet radiation in Canada\u201d [Prev. Med. 122 (2019) 81-90]","volume":"126","author":"O'Sullivan","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.ejca.2021.09.044_bib9","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/jdv.15022","article-title":"Cutaneous melanoma in France in 2015 attributable to solar ultraviolet radiation and the use of sunbeds","volume":"32","author":"Arnold","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"10.1016\/j.ejca.2021.09.044_bib10","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1038\/bjc.2011.486","article-title":"13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010","volume":"105","author":"Parkin","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2021.09.044_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/ijc.31527","article-title":"Global burden of cutaneous melanoma attributable to ultraviolet radiation in 2012","volume":"143","author":"Arnold","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2021.09.044_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1600-0463.1997.tb05613.x","article-title":"Avoidable cancers in the Nordic countries. Radiation","volume":"76","author":"Winther","year":"1997","journal-title":"APMIS Suppl"},{"key":"10.1016\/j.ejca.2021.09.044_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/02841861003782017","article-title":"NORDCAN--a Nordic tool for cancer information, planning, quality control and research","volume":"49","author":"Engholm","year":"2010","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2021.09.044_bib14","author":"Krebsregister Saarland"},{"key":"10.1016\/j.ejca.2021.09.044_bib15","author":"Statistics Denmark"},{"key":"10.1016\/j.ejca.2021.09.044_bib16","author":"Statistisches Amt Saarland"},{"key":"10.1016\/j.ejca.2021.09.044_bib17","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/jdv.15322","article-title":"Time trends in incidence and mortality of cutaneous melanoma in Germany","volume":"33","author":"Garbe","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2021.09.044_bib18","first-page":"S1","article-title":"Prediction of cancer incidence in the Nordic countries up to the year 2020","volume":"11","author":"Moller","year":"2002","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.ejca.2021.09.044_bib19","author":"NORDPRED"},{"key":"10.1016\/j.ejca.2021.09.044_bib20","series-title":"An introduction to medical statistics","author":"Bland","year":"2000"},{"key":"10.1016\/j.ejca.2021.09.044_bib21","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2021.09.044_bib22","first-page":"219","article-title":"Cutaneous melanoma","volume":"19\u201320","author":"Armstrong","year":"1994","journal-title":"Cancer Surv"},{"key":"10.1016\/j.ejca.2021.09.044_bib23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/labinvest.2016.155","article-title":"Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance","volume":"97","author":"Day","year":"2017","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2021.09.044_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/35095108","article-title":"Neonatal sunburn and melanoma in mice","volume":"413","author":"Noonan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2021.09.044_bib25","first-page":"4061","article-title":"Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility","volume":"58","author":"Kelsall","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2021.09.044_bib26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature13298","article-title":"Ultraviolet radiation accelerates BRAF-driven melanomagenesis by targeting TP53","volume":"511","author":"Viros","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2021.09.044_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic","volume":"30","author":"Chan","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.09.044_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"Suppl 2","key":"10.1016\/j.ejca.2021.09.044_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jdv.15320","article-title":"Epidemiological evidence of carcinogenicity of sunbed use and of efficacy of preventive measures","volume":"33","author":"Gandini","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2021.09.044_bib30","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3491","article-title":"Melanoma epidemiology and sun exposure","volume":"100","author":"Raimondi","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejca.2021.09.044_bib31","doi-asserted-by":"crossref","first-page":"e4757","DOI":"10.1136\/bmj.e4757","article-title":"Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis","volume":"345","author":"Boniol","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.ejca.2021.09.044_bib32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jid.2016.01.035","article-title":"The growing burden of invasive melanoma: projections of incidence rates and numbers of new cases in six susceptible populations through 2031","volume":"136","author":"Whiteman","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ejca.2021.09.044_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/ijc.28956","article-title":"Melanoma incidence trends and survival in adolescents and young\u00a0adults in Queensland, Australia","volume":"136","author":"Iannacone","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2021.09.044_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States","volume":"156","author":"Paulson","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2021.09.044_bib35","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/1403494813479216","article-title":"Cutaneous malignant melanoma incidence rates in Norway","volume":"41","author":"Moan","year":"2013","journal-title":"Scand J Public Health"},{"issue":"Suppl 2","key":"10.1016\/j.ejca.2021.09.044_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2133.2012.11087.x","article-title":"Potential impact of interventions resulting in reduced exposure to ultraviolet (UV) radiation (UVA and UVB) on skin cancer incidence in four European countries, 2010-2050","volume":"167","author":"de Vries","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2021.09.044_bib37","volume":"vol. XI (electronic version)","author":"Bray","year":"2017"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101145X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492101145X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:33:35Z","timestamp":1760733215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492101145X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":37,"alternative-id":["S095980492101145X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.09.044","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.741122385.793590678","asserted-by":"object"}]},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous melanoma attributable to UVR exposure in Denmark and Germany","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.09.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}